Beta glucans

from Wikipedia, the free encyclopedia

Beta-glucans (β-glucans) are a group of high-molecular β-D-glucose polysaccharides which are found in the cell walls of cereals, bacteria and fungi. Depending on the source, they have significantly different physicochemical properties. Also, cellulose and chitin are glucans with β- glycosidic linkage . Some β-glucans have anti-tumor and anti-inflammatory effects.

properties

A daily intake of 3 g beta-glucan from barley reduces the LDL level and can lower the risk of cardiovascular disease . Some studies suggest that beta-glucans from grains also have immunomodulatory properties. Beta-glucans are used as soluble fiber in various medically used food supplements and in cosmetic products, as well as texturizing agents in foods. When brewing beer , beta-glucans are produced as undesirable by-products, as they are an indicator of reduced malting and increase the viscosity of the wort .

Beta-glucans with β- (1 → 3) and β- (1 → 6) branches bind to the receptors dectin-1 , complement receptor 3 (CR3) and toll-like receptors (TLR).

Beta-glucans were first discovered in lichens and shortly afterwards in barley.

Occurrence

β-glucans are a natural component of the cell walls of bacteria, fungi, yeast and cereals such as oats and barley. The different types of beta-glucans are characterized by different molecular structures, also by different degrees of branching and different molecular weights, which cause their solubility and physiological properties. Beta-glycosidic bonds cannot be metabolized by humans because they do not have enzymes to break the β-glycosidic bond. That is why beta-glucans belong to the fiber category.

Beta-glucans from cereals consist of β-1,3 and β-1,4 linked D-glucopyranose units. Yeast beta-glucans are β-1,3- and β-1,6-glyosidically linked. The beta-glucans in barley are 27% in the walls of the aleuron cells and 73% in the cell walls of the endosperm , while the beta-glucans in oats are concentrated in the subaleuron layer. The bread grains wheat (0.8%) and rye (2.3%) contain only small amounts of beta-glucan. One of the most common sources of beta-1,3-D- glucans for dietary supplements is obtained from the cell wall of the baker's yeast Saccharomyces cerevisiae . The β (1,3) D-glucans obtained from baker's yeast are often insoluble. Beta-1,3- and beta-1,4-glucans are also extracted from oat bran and from the core of barley. The grains of beta-glucan barley also serve as a beta-glucan supplier in the form of barley flakes and barley flour for bread and baked goods. Other sources include some types of algae and different types of mushrooms such as Reishi ( Shiny Lackporling , Ganoderma lucidum ), Ganoderma applanatum , Shiitake , Chaga ( Slate Schillerporling ), and Maitake ( Common Rattles ).

effect

Beta-glucans from oats and barley produce a variety of physiological effects, some of which have a positive effect on health. Barley and oat β- glucans were studied in subjects with hypercholesterolemia for their effects on reducing the risk of heart attack. Beta-1,3 / 1,4-glucan presumably lowers a high cholesterol level and thus reduces an important risk factor for vascular diseases such as arteriosclerosis, high blood pressure, heart attack and stroke.

Beta-glucans from grains increase the viscosity of the chyme in the gastrointestinal tract if the concentration in food is sufficiently high . They delay the breakdown of nutrients, especially the breakdown of carbohydrates into sugar and their absorption into the blood. The consumption of oat and barley products with a high beta-glucan content leads to a lower increase in blood sugar level after meals and a reduced secretion of insulin. The risk of obesity and other diet-related diseases such as type 2 diabetes, heart attack and stroke decreases.

As soluble fiber, the beta-glucans are fermented by the intestinal flora to form anions of short-chain fatty acids such as acetate, butyrate and propionate. The resulting lowering of the pH value prevents in particular the colonization of the colon by pathogenic germs. Short-chain fatty acids are important regulators for a healthy metabolism. Butyrate is the most important source of energy for the intestinal mucous membrane cells and has an anti-inflammatory effect.

β-D-glucan is part of the cell wall of certain medically relevant fungi, in particular the fungus species watering can mold ( Aspergillus ) and mushrooms (also Agaricus ). The determination of the presence of β-D-glucan in the blood is therefore also marketed as a method for diagnosing invasive fungal infections in patients. False positives can result from fungus - contamination in antibiotics such as clavulanic acid - amoxicillin , and piperacillin / tazobactam occur. False positive results can also occur due to contamination of clinical samples with the bacteria Streptococcus pneumoniae , Pseudomonas aeruginosa and Alcaligenes faecalis , which also produce (1 → 3) β-D-glucan. Fungal beta-glucans have been recognized as "modifiers of the biological immune response". Beta-1,3-1,6- glucans as essential components of the cell walls of fungi, some plants and bacteria are structures that are recognized by our immune system as quasi-pathogens. Without being a pathogen, they trigger immune activation, but do not cause symptoms of illness. Beta-glucans are recognized and absorbed by phagocytes via special receptors (Dectin-1 and others). As a result, the phagocytes activate the formation of additional cells for the immune defense, which can then protect the body from new pathogens in the blood and lymphatic systems. This regulation of the immune response also causes anti-tumor properties. Several studies have found effects on epithelial cell cytokine production.

Individual evidence

  1. KM Bashir, JS Choi: Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future. In: International journal of molecular sciences. Volume 18, number 9, September 2017, p., Doi : 10.3390 / ijms18091906 , PMID 28872611 , PMC 5618555 (free full text).
  2. Official Journal of the European Union, Regulation (EU) No. 1048/2012 of the Commission of November 8, 2012 on the authorization of a health claim on food relating to the reduction of a disease risk, Article 14 paragraph 1 letter a: health claim on the reduction of a disease risk.
  3. HV Ho, JL Sievenpiper, A. Zurbau, S. Blanco Mejia, E. Jovanovski, F. Au-Yeung, AL Jenkins, V. Vuksan: The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomized-controlled trials. In: The British journal of nutrition. Volume 116, Number 8, October 2016, pp. 1369-1382, doi : 10.1017 / S000711451600341X , PMID 27724985 .
  4. V. Sileoni, O. Marconi, G. Perretti: Near-infrared Spectroscopy in the Brewing Industry. In: Critical reviews in food science and nutrition. Volume 55, number 12, 2015, pp. 1771–1791, doi : 10.1080 / 10408398.2012.726659 , PMID 24915307 .
  5. N. Dalonso, GH Goldman, RM Gern: β- (1 → 3), (1 → 6) -glucans: medicinal activities, characterization, biosynthesis and new horizons. In: Applied Microbiology and Biotechnology . Volume 99, Number 19, October 2015, pp. 7893-7906, doi : 10.1007 / s00253-015-6849-x , PMID 26252967 .
  6. ^ Bhatty, RS (1986). Physiochemical and functional breadmaking properties of hull-les barley fractions . Cereal Chemistry. 63 (1): 31.
  7. Ternes, W. (1994). Scientific basics of food preparation . Behrs publishing house. 2nd Edition.
  8. Teas, J (1983). The dietary intake of laminarin, a brown seaweed, and breast cancer prevention . Nutrition and cancer. Lawrence Erlbaum Associates. 4 (3): 217-222. doi: 10.1080 / 01635588209513760 , PMID 6302638 .
  9. Isolation and characterization of antitumor active β-d-glucans from the fruit bodies of Ganoderma applanatum . Carbohydrate Research. 115, April 16, 1983: 273-280. doi: 10.1016 / 0008-6215 (83) 88159-2 .
  10. water, SP; Weis AL (1999). Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective . Critical reviews in immunology. United States: Begell House. 19 (1): 65-96. doi: 10.1615 / critrevimmunol.v19.i1.30 , PMID 9987601 .
  11. Keogh, GF; Cooper GJ; Mulvey TB; McArdle bra; Coles GD; Monro YES; Poppitt SD (October 2003). Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men . The American Journal of Clinical Nutrition. United States: American Society of Clinical Nutrition. 78 (4): 711-718. PMID 14522728 .
  12. Braaten JT, Wood PJ, Scott FW, Wolynetz MS, Lowe MK, Bradley-White P, Collins MW: Oat (-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects . Eur J Clin Nutrition 1994; 48: 465-474.
  13. ^ Anttila H., Sontag-Strohm T and Salovaara H. (2004). Viscosity of beta-glucan in oat products . Agricultural and Food Science. 13: 80-87.
  14. Official Journal of the European Union, Regulation (EU) No. 1048/2012 of the Commission of November 8, 2012 on the authorization of a health claim on food relating to the reduction of a disease risk, Article 14 paragraph 1 letter a: health claim on the reduction of a disease risk.
  15. EFSA Panel on Dietetic Products NaAN (2011). Scientific Opinion on the substantiation of health claims related to beta-glucans from oats and barley and maintenance of normal blood LDL-cholesterol concentrations (ID 1236, 1299), increase in satiety leading to a reduction in energy intake (ID 851, 852), reduction of post-prandial glycaemic responses (ID 821, 824), and “digestive function” '(ID 850) pursuant to Article 13 (1) of Regulation (EC) . No 1924/2006. EFSA Journal 9: 2207 [21 pp.].
  16. Kasper, H. (2000). Nutritional medicine and dietetics . Chapter 1. 76-85 (2.1.). Urban & Fischer Verlag. Munich / Jena.
  17. ^ German Nutrition Society (DGE) eV (2013). A new look at fiber . DGInfo. 08: 114-118.
  18. Obayashi T, Yoshida M, Mori T, et al. (1995). Plasma (13) -beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes . Lancet. 345 (8941): 17-20. doi: 10.1016 / S0140-6736 (95) 91152-9 .
  19. Ostrosky-signatory L, Alexander BD, Kett DH, et al. (2005). Multicenter clinical evaluation of the (1 → 3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans . Clin Infect Dis. 41 (5): 654-659. doi: 10.1086 / 432470 , PMID 16080087 .
  20. Odabasi Z, Mattiuzzi G, Estey E, et al. (2004). Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome . Clin Infect Dis. 39 (2): 199-205. doi: 10.1086 / 421944 , PMID 15307029 .
  21. Mennink-Kersten MA, Warris A, Verweij PE (2006). 1,3-β-D-glucan in patients receiving intravenous amoxicillin – clavulanic acid . NEJM. 354 (26): 2834-2835. doi: 10.1056 / NEJMc053340 , PMID 16807428 .
  22. Mennink-Kersten MA, Ruegebrink D, Verweij PE (2008). Pseudomonas aeruginosa as a cause of 1,3-β-D-glucan assay reactivity . Clin Infect Dis. 46 (12): 1930-1931. doi: 10.1086 / 588563 , PMID 18540808 .
  23. Miura, NN; Ohno N; Aketagawa J; Tamura H; Tanaka S; Yadomae T (January 1996). Blood clearance of (1 → 3) -beta-D-glucan in MRL lpr / lpr mice . FEMS Immunology and Medical Microbiology. England: Blackwell Publishing. 13 (1): 51-57. doi: 10.1016 / 0928-8244 (95) 00083-6 , PMID 8821398 .
  24. Brown, GD; Gordon, S (Sep 6, 2001). Immune recognition. A new receptor for beta-glucans . Nature. 413 (6851): 36-7. bibcode : 2001Natur.413 ... 36B . doi: 10.1038 / 35092620 , PMID 11544516 .
  25. Vetvicka, V; Dvorak B; Vetvickova J; Judge J; Krizan J; Sima P; Yvin JC (2007-03-10). Orally administered marine (1 → 3) -beta-D-glucan Phycarine stimulates both humoral and cellular immunity . International journal of biological macromolecules. England: Butterworth-Heinemann. 40 (4): 291-298. doi: 10.1016 / j.ijbiomac.2006.08.009 , PMID 16978690 .
  26. ^ Adams, Elizabeth L (2008). Differential High-Affinity Interaction of Dectin-1 with Natural or Synthetic Glucans Is Dependent upon Primary Structure and Is Influenced by Polymer Chain Length and Side-Chain Branching . The Journal of Pharmocology and Experimental Therapeutics.
  27. ^ Wasser, SP (November 2002). Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides . Applied Microbiology and Biotechnology.
  28. Barsanti, Laura (January 17, 2011). Chemistry, physico-chemistry and applications linked to biological activities of β-glucans. Natural Product Reports.
  29. Kim, Hyung Sook (August 2011). Stimulatory Effect of β-glucans on Immune Cells . Immune Network.
  30. Tsukada, C; Yokoyama H; Miyaji C; Ishimoto Y; Kawamura H; Subscription T (January 2003). Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan . Cellular immunology. United States: Academic Press. 221 (1): 1-5. doi: 10.1016 / S0008-8749 (03) 00061-3 , PMID 12742376 .

See also